Vivekkumar K. Redasani

Vivekkumar K. Redasani

Auto-generated profile, based on publicly available information

Vivekkumar K. Redasani

Director and Principal YSPM,s YTC. Satara 415011, Maharashtra, India

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 August 2023 in Asian Journal of Pharmaceutical Research and Development
Verified
Journal Article
Open access
PDF file
RPRutuja Patole
Rutuja Patole
BCBharatee Chaware
Bharatee Chaware
VMVishal Mohite
Vishal Mohite
VRVivekkumar Redasani
Vivekkumar Redasani
Inadequate pharmacokinetic properties may be connected with the widespread use of oral dose forms in disease treatment. Because of the formulation's rapid transit through the gastrointestinal tract (GIT), it can be challenging to achieve therapeutic levels of the medicine in specific situations when it is barely soluble; In addition, some medications must work locally due to a gastric disease, although they only last a short period in the stomach. Numerous studies have been done to identify formulations that can enhance all of these characteristics while extending stomach residence time. Many orally delivered medications advantageous for from the extended stomach retention time provided by gastroretentive controlled drug delivery systems.With a focus on current methods for extending stomach residence duration, the study's objective was to examine, gather, and present the preceding and contemporary literatures in a shorter format. The current review briefly discusses the need for GRDDS., Pharmaceutical importance’s of GRDDS, Physiology of stomach, Stomach functionalities, Approaches of GRDDS, factors controlling gastric retention, advantages , disadvantages, Method of preparation of Gastro-retentive Multiparticulate system, Polymeric material in gastroretentive formulations, Evaluation of Gastroretentive dosage form, comparsion between Conventional and Gastroretentive drug delivery system.  

15 July 2025 in Journal of Drug Delivery and Therapeutics
Verified
Journal Article
Open access
PDF file
SLShivanjali S. Lakhapate
Shivanjali S. Lakhapate
ODOmkar A. Devade
Omkar A. Devade
VRVivekkumar K. Redasani
Vivekkumar K. Redasani
Cervical spondylosis is a common degenerative condition affecting the cervical spine, predominantly in individuals over the age of 40. This comprehensive review explores its epidemiology, pathogenesis, and clinical manifestations, including cervical radiculopathy, myelopathy, and axial joint pain. The degenerative changes, originating from intervertebral disc dehydration and osteophyte formation, lead to symptoms ranging from localized neck pain to neurological deficits. Diagnosis primarily relies on clinical evaluation, supported by imaging modalities such as MRI and CT scans. Non-surgical management includes physical therapy, pharmacological interventions, and alternative therapies, including acupuncture and yoga. For severe or refractory cases, surgical options like anterior cervical discectomy and posterior laminoplasty are discussed. Despite advancements in diagnosis and management, the chronic nature of the condition necessitates a multidisciplinary approach to minimize disability and improve quality of life. This review underscores the need for further research into effective long-term treatments and preventive strategies for cervical spondylosis. Keywords: Cervical spondylosis Epidemiology, Pathophysiology, Types, Diagnosis, Surgical Treatment, Alternative treatment, non-surgical treatment